Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
Showcase your company news with guaranteed exposure both in print and online Innovation Awards will honor individuals, teams and companies who have developed innovative approaches and solutions… Join ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results